References
- 1. Toxic Exposure Surveillance System (TESS). Washington (DC): American Association of Poison Control Centers, 2004. Database accessed June 2005
- Chong LL, Chau WK, Ho CH. A case of “superwarfarin” poisoning. Scand J Haematol 1986; 36: 314–315
- Chua JD, Friedenberg WR. Superwarfarin poisoning. Arch Intern Med 1998; 158: 1929–1932
- Jones EC, Growe GH, Naiman SC. Prolonged anticoagulation in rat poisoning. JAMA 1984; 252: 3005–3007
- Park BK, Choonara IA, Haynes BP, Breckenridge AM, Malia RG, Preston FE. Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins. Br J Clin Pharmacol 1986; 21: 289–293
- Svendsen SW, Kolstad HA, Steesby E. Bleeding problems associated with occupational exposure to anticoagulant rodenticides. Int Arch Occup Environ Health 2002; 75: 515–517
- Babcock J, Hartman K, Pedersen A, Murphy M, Alving B. Rodenticide-induced coagulopathy in a young child. A case of Munchausen syndrome by proxy. Am J Pediatr Hematol Oncol 1993; 15: 126–130
- Spiller HA, Gallenstein GL, Murphy MJ. Dermal absorption of a liquid diphacinone rodenticide causing coagulaopathy. Vet Hum Toxicol 2003; 45: 313–314
- La Rosa FG, Clarke SH, Lefkowitz JB. Brodifacoum intoxication with marijuana smoking. Arch Pathol Lab Med 1997; 121: 67–69
- Waien SA, Hayes D, Leonardo JM. Severe coagulopathy as a consequence of smoking crack cocaine laced with rodenticide. N Engl J Med 2001; 345: 700–701
- Bachmann KA, Sullivan TJ. Dispositional and pharmacodynamic characteristics of brodifacoum in warfarin-sensitive rats. Pharmacology 1983; 27: 281–288
- Leck JB, Park BK. A comparative study of the effects of warfarin and brodifacoum on the relationship between vitamin K1 metabolism and clotting factor activity in warfarin-susceptible and warfarin-resistant rats. Biochem Pharmacol 1981; 30: 123–128
- Park BK, Leck JB. A comparison of vitamin K antagonism by warfarin, difenacoum and brodifacoum in the rabbit. Biochem Pharmacol 1982; 31: 3635–3639
- Hollinger BR, Pastoor TP. Case management and plasma half-life in a case of brodifacoum poisoning. Arch Intern Med 1993; 153: 1925–1928
- Pavlu J, Harrington DJ, Voong K, Savidge GF, Jan-Mohamed R, Kaczmarski R. Superwarfarin poisoning. Lancet 2005; 365. 628
- Weitzel JN, Sadowski JA, Furie BC, Moroose R, Kim H, Mount ME, Murphy MJ, Furie B. Surreptitious ingestion of a long-acting vitamin K antagonist/rodenticide, brodifacoum: clinical and metabolic studies of three cases. Blood 1990; 76: 2555–2559
- Bruno GR, Howland MA, McMeeking A, Hoffman RS. Long-acting anticoagulant overdose: brodifacoum kinetics and optimal vitamin K dosing. Ann Emerg Med 2000; 36: 262–267
- Lipton RA, Klass EM. Human ingestion of a “superwarfarin” rodenticide resulting in a prolonged anticoagulant effect. JAMA 1984; 252: 3004–3005
- Burucoa C, Mura P, Robert R, Boinot C, Bouquet S, Piriou A. Chlorophacinone intoxication. A biological and toxicological study. J Toxicol Clin Toxicol 1989; 27: 79–89
- Lagrange F, Corniot AG, Titier K, Bedry R, Pehourcq F. Toxicological management of chlorophacinone poisoning. Acta Clin Belg Suppl 1999; 1: 13–16
- McCarthy PT, Cox AD, Harrington DJ, Evely RS, Hampton E, al-Sabah AI, Massey E, Jackson H, Ferguson T. Covert poisoning with difenacoum: clinical and toxicological observations. Hum Exp Toxicol 1997; 16: 166–170
- Ingels M, Lai C, Tai W, Manning BH, Rangan C, Williams SR, Manoguerra AS, Albertson T, Clark RF. A prospective study of acute, unintentional, pediatric superwarfarin ingestions managed without decontamination. Ann Emerg Med 2002; 40: 73–78
- Seidelmann S, Kubic V, Burton E, Schmitz L. Combined superwarfarin and ethylene glycol ingestion. A unique case report with misleading clinical history. Am J Clin Pathol 1995; 104: 663–666
- Smolinske SC, Scherger DL, Kearns PS, Wruk KM, Kulig KW, Rumack BH. Superwarfarin poisoning in children: a prospective study. Pediatrics 1989; 84: 490–494
- Barnett VT, Bergmann F, Humphrey H, Chediak J. Diffuse alveolar hemorrhage secondary to superwarfarin ingestion. Chest 1992; 102: 1301–1302
- Emre S, Kitabayashi K, Miller CM. Successful liver transplantation from a donor with brodifacoum intoxication. Liver Transpl Surg 1999; 5: 509–511
- Kruse JA, Carlson RW. Fatal rodenticide poisoning with brodifacoum. Ann Emerg Med 1992; 21: 331–336
- Zupancic-Salek S, Kovacevic-Metelko J, Radman I. Successful reversal of anticoagulant effect of superwarfarin poisoning with recombinant activated factor VII. Blood Coagul Fibrinolysis 2005; 16: 239–244
- Casner PR. Superwarfarin toxicity. Am J Ther 1998; 5: 117–120
- Hoffman RS, Smilkstein MJ, Goldfrank LR. Evaluation of coagulation factor abnormalities in long-acting anticoagulant overdose. J Toxicol Clin Toxicol 1988; 26: 233–248
- Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999; 281: 1900–1905
- Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization. Ann Intern Med 2003; 139: 493–498
- Burkhart KK. Anticoagulant rodenticides. Clinical toxicology, MD Ford, KA Delaney, J Ling, T Erickson. WB Saunders, Philadelphia 2001; 848–853
- Metts BC, Stewart NJ. Rodenticides. Clinical management of poisoning and drug overdose3rd, LM Haddad, MW Shannon, JF Winchester. WB Saunders, Philadelphia 1998; 864–875
- Su M, Hoffman RS. Anticoagulants. Goldfrank's toxicologic emergencies7th, LR Goldfrank, NE Flomenbaum, NA Lewin, MA Howland, RS Hoffman, LS Nelson. McGraw-Hill, New York 2002; 631–646
- Yip L. Anticoagulant rodenticides. Medical toxicology3rd, RC Dart. Williams & Wilkins, Baltimore 2004; 1497–1507
- Anticoagulants. long-acting management. Poisindex System, RK Klasco. Thomson Micromedex, Greenwood Village, CO, edition expires September 2004
- Shepherd G, Klein-Schwartz W, erson BD. Acute, unintentional pediatric brodifacoum ingestions. Pediatr Emerg Care 2002; 18: 174–178
- Bennett DL, Caravati EM, Veltri JC. Long-acting anticoagulant ingestion: a prospective study [abstract]. Vet Hum Toxicol 1987; 29: 472–473
- Brands CS, Bartkus EA, Daya MR. Accidental superwarfarin ingestion: compliance with current Poisindex® guidelines [abstract]. J Toxicol Clin Toxicol 1995; 33. 487
- Kanabar D, Volans G. Accidental superwarfarin poisoning in children—less treatment is better. Lancet 2002; 360. 963
- Morrissey B, Burgess JL, Robertson WO. Washington's experience and recommendations. Re: anticoagulant rodenticides. Vet Hum Toxicol 1995; 37: 362–363
- Mullins ME, Brands CL, Daya MR. Unintentional pediatric superwarfarin exposures: do we really need a prothrombin time?. Pediatrics 2000; 105: 402–404
- Polley K, Nichols MH, King WD. Superwarfarin ingestion: is observation alone the answer? [abstract]. J Investig Med 1996; 44. A28
- Sullivan MP, Dean BS, Krenzelok EP. Long-acting anticoagulant rodenticides: an evaluation of 88 cases [abstract]. Vet Hum Toxicol 1989; 31. 361
- Chuang J, Sadler MA, Witt DM. Impact of evacuated collection tube fill volume and mixing on routine coagulation testing using 2.5-mL (pediatric) tubes. Chest 2004; 126: 1262–1266
- Boyer LV, Griffith L, Fosdick CC, III, Fernandez M. Prolonged coagulopathy after brodifacoum ingestion and the challenges in provision of continuing care [abstract]. J Toxicol Clin Toxicol 1998; 36. 462
- Chen TW, Deng JF. A brodifacoum intoxication case of mouthful amount [abstract]. Vet Hum Toxicol 1986; 28. 488
- Lewis-Younger C, Horowitz Z. Elimination of brodifacoum [abstract]. J Toxicol Clin Toxicol 2001; 39: 474–475
- Morgan BW, Tomaszewski C, Rotker I. Spontaneous hemoperitoneum from brodifacoum overdose. Am J Emerg Med 1996; 14: 656–659
- Ross GS, Zacharski LR, Robert D, Rabin DL. An acquired hemorrhagic disorder from long-acting rodenticide ingestion. Arch Intern Med 1992; 152: 410–412
- Sheen SR, Spiller HA, Grossman D. Symptomatic brodifacoum ingestion requiring high-dose phytonadione therapy. Vet Hum Toxicol 1994; 36: 216–217
- Zurawski JM, Kelly EA. Pregnancy outcome after maternal poisoning with brodifacoum, a long-acting warfarin-like rodenticide. Obstet Gynecol 1997; 90: 672–674
- Haug B, Schjodt-Iversen L, Rygh J. Forgiftninger med langtidsvirkende antikoagulanter. Tidsskr Nor Laegeforen 1992; 112: 1958–1960
- Chataigner D, Garnier R, Elmalem J, Efthymiou ML. Hypocoagulabilit& eacute; prolong& eacute;e secondaire & agrave; l'ingestion de raticides anticoagulants. Ann Med Interne (Paris) 1989; 139: 537–541
- Murdoch DA. Prolonged anticoagulation in chlorphacinone poisoning. Lancet 1983; 1: 355–356
- Vogel JJ, de Moerloose P, Bouvier CA, Gaspoz J, Riant P. Anticoagulation prolong& eacute;e lors d'une intoxication & agrave; la chlorphacinone. Schweiz Med Wochenschr 1988; 118: 1915–1917
- Barlow AM, Gay AL, Park BK. Difenacoum (Neosorexa) poisoning. Br Med J (Clin Res Ed) 1982; 285. 541
- Hayes WJ. Pesticides studied in man. Williams & Wilkins, Baltimore 1982; 512–513
- Field JB, Goldfarb MS, Ware AG, Griffith GC. Dipaxin: 2-diphenylacetyl-1,3-indandione; clinical evaluation of a new anticoagulant. Circulation 1955; 11: 576–583
- Pascale LR, Olwin JH. Clinical experience with a new anticoagulant, dipaxin (2-diphenylacetyl-1,3-indandione). Circulation 1954; 9: 230–237
- Corke PJ. Superwarfarin (brodifacoum) poisoning. Anaesth Intensive Care 1997; 25: 707–709
- Tsutaoka BT, Miller M, Fung SM, Patel MM, Olson KR. Superwarfarin and glass ingestion with prolonged coagulopathy requiring high-dose vitamin K1 therapy. Pharmacotherapy 2003; 23: 1186–1189
- Butcher GP, Shearer MJ, MacNicoll AD, Kelly MJ, Ind PW. Difenacoum poisoning as a cause of haematuria. Hum Exp Toxicol 1992; 11: 553–554
- Terneu S, Verhelst D, Thys F, Ketelslegers E, Hantson P, Wittebole X. An unusual cause of abdominal pain. Acta Clin Belg 2003; 58: 241–244
- Greeff MC, Mashile O, MacDougall LG. “Superwarfarin” (bromodialone) poisoning in two children resulting in prolonged anticoagulation. Lancet 1987; 2. 1269
- Watts RG, Castleberry RP, Sadowski JA. Accidental poisoning with a superwarfarin compound (brodifacoum) in a child. Pediatrics 1990; 86: 883–887
- Dahl B, Caravati M, Dunson W. Surreptitious brodifacoum poisoning [abstract]. J Toxicol Clin Toxicol 1998; 36: 475–476
- Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactationSixth. Williams and Wilkins, Baltimore 2002; 327–334
- Donovan JW, Ballard JO, Murphy MJ. Brodifacoum therapy with activated charcoal: effect on elimination kinetics [abstract]. Vet Hum Toxicol 1990; 32. 350
- www.epa.gov/REDs/2100red.pdf, Environmental Protection Agency (US), Reregistration Eligibility Decision (RED): Rodenticide ClusterJulyEPA 738-R-98–007. 1998Document accessed June 6, 2005